Salud financiera de hoja de balance de Flora Growth

Salud financiera controles de criterios 5/6

Flora Growth tiene un patrimonio de los accionistas total de $6.4M y una deuda total de $1.9M, lo que sitúa su ratio deuda-patrimonio en 30.2%. Sus activos y pasivos totales son $23.6M y $17.2M respectivamente.

Información clave

98.1%

Ratio deuda-patrimonio

US$3.08m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	US$4.16m
Patrimonio	US$3.14m
Total pasivo	US$21.14m
Activos totales	US$24.27m

Actualizaciones recientes sobre salud financiera

Recent updates

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Apr 04

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

Feb 17

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Dec 22

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Apr 17

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Dec 08

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($21.4M) de FLGC superan a sus pasivos a corto plazo ($16.3M).

Pasivo a largo plazo: Los activos a corto plazo de FLGC ($21.4M) superan a sus pasivos a largo plazo ($942.0K).

Historial y análisis de deuda-patrimonio

Nivel de deuda: FLGC tiene más efectivo que su deuda total.

Reducción de la deuda: No se dispone de datos suficientes para determinar si el ratio deuda-patrimonio de FLGC se ha reducido en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: FLGC tiene suficiente cash runway para 6 meses según el flujo de caja libre último declarado, pero desde entonces ha obtenido capital adicional.

Pronóstico de cash runway: Se prevé que FLGC disponga de suficiente cash runway para 4 meses según las estimaciones de flujo de caja libre, aunque ha obtenido desde entonces capital adicional.

Salud financiera de hoja de balance de Flora Growth

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

Flora Growth Corp. Receives Non-Compliance Notice From NASDAQ

Flora Growth Regains Compliance with Nasdaq Minimum Bid Requirement

Recent updates

Forecast to breakeven in 2025

First quarter 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Shareholder dilution

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Flora Growth Corp. has completed a Follow-on Equity Offering in the amount of $3.23 million.

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

New major risk - Market cap size

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Flora Growth Corp. Receives Non-Compliance Notice From NASDAQ

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

Flora Growth Corp. Announces the Resignation of Juan Carlos Roa Gomez as Director

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. (NasdaqCM : FLGC) entered into a Sale and Purchase Agreement to acquire Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST) for $1.9 million.

Second quarter 2023 earnings: Revenues miss analyst expectations

Flora Growth Corp. Announces Resignation of Matthew Cohen as General Counsel

Flora Growth Corp. Appoints Dany Vaiman as Chief Financial Officer

Flora Growth Regains Compliance with Nasdaq Minimum Bid Requirement

Consensus EPS estimates upgraded to US$0.03 loss

Flora Growth Corp. Announces Board Appointments

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates upgraded to US$0.21 loss

Price target decreased by 24% to US$1.33

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Price target increased by 18% to US$2.92

Flora Growth Corp Provides Revenue Guidance for the Year 2023

Flora Growth Corp. Announces Executive Changes

Price target decreased to US$2.12

Forecast to breakeven in 2024

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Independent Director notifies of intention to sell stock

Third quarter 2022 earnings: EPS misses analyst expectations

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Price target decreased to US$2.67

High number of new and inexperienced directors

Flora Growth Corp. (NasdaqCM:FLGC) entered into a definitive agreement to acquire Franchise Global Health Inc. (TSXV:FGH) for CAD 32.2 million.

No longer forecast to breakeven

Flora Growth gains on deal to acquire No Cap Hemp assets

First half 2022 earnings released: US$0.42 loss per share (vs US$0.13 loss in 1H 2021)

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Flora Growth Corp. to Report First Half, 2022 Results on Aug 15, 2022

High number of new and inexperienced directors

Flora Growth Appoints Elshad Garayev as Chief Financial Officer

Elshad Garayev is the new finance chief of Flora Growth

Flora Growth Corp. Announces Board Appointments

Flora Growth Corp. (NasdaqCM:FLGC) announces an Equity Buyback for $5 million worth of its shares.

Flora Growth Corp., Annual General Meeting, Jul 05, 2022

Flora Growth Corp. (NasdaqCM:FLGC) and Annabelle Manalo-Morgan agreed to acquire Masaya Medical, Inc.

Flora Growth Corp. Reiterates Earnings Guidance for the Full Year 2022

Flora Growth Corp. to Report Fiscal Year 2021 Results on May 10, 2022

Flora Growth Corp. Announces Launch of New Skincare Line Under Its Brand, MIND Naturals

High number of new and inexperienced directors

Flora Growth Corp. Appoints Jessie Casner as Chief Marketing Officer to Drive Growth of Brand Portfolio

Flora Growth Registers First-Ever Cannabinoid Food and Beverage Products with Colombian-FDA

Flora Growth Corp. Names Vessel Founder, James Choe, Chief Strategy Officer

Flora Growth Corp. Appoints Derek Pedro as an Advisor to its Cosechemos Cultivation Facility

Flora Growth Appoints Joël Reyes as SVP of Global Operations

Flora Ready To Grow Like A Weed

High number of new and inexperienced directors

Flora Growth Corp. Provides Revenue Guidance for the Year 2022

Flora Growth: Cheap Cannabis Appeal

Flora Growth CEO Luis Merchan - Growing A Global Cannabis Brand (Video)

Flora Growth Corp. Provides Financial Guidance for the Second Half of 2021

Flora Growth Corp. (NasdaqCM:FLGC) entered into a letter of intent to acquire Vessel Brand, Inc. for $30 million.

Flora Growth Corp. (NasdaqCM:FLGC) signed a Letter of Intent to acquire Koch & Gsell AG for $22.2 million.

Flora Growth bolsters leadership team with new hires

Flora Growth Corp. (NasdaqCM:FLGC) acquired Quipropharma Lab.

Flora Growth Corp. has completed an IPO in the amount of $16.666665 million.

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio